Cargando…

Design, Formulation, and Characterization of Valsartan Nanoethosomes for Improving Their Bioavailability

The objective of this study was to formulate and evaluate valsartan (VLT) ethosomes to prepare an optimized formula of VLT-entrapped ethosomes that could be incorporated into a sustained release transdermal gel dosage form. The formulation of the prepared ethosomal gel was investigated and subjected...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nasr, Ali M., Moftah, Fayrouz, Abourehab, Mohammed A. S., Gad, Shadeed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696396/ https://www.ncbi.nlm.nih.gov/pubmed/36365087 http://dx.doi.org/10.3390/pharmaceutics14112268

Ejemplares similares

Nanoethosomal transdermal delivery of vardenafil for treatment of erectile dysfunction: optimization, characterization, and in vivo evaluation
por: Fahmy, Usama A
Publicado: (2015)

A novel transdermal nanoethosomal gel of betahistine dihydrochloride for weight gain control: in-vitro and in-vivo characterization
por: El-Menshawe, Shahira F, et al.
Publicado: (2017)

Design and Optimization of Orally Administered Luteolin Nanoethosomes to Enhance Its Anti-Tumor Activity against Hepatocellular Carcinoma
por: Elsayed, Mahmoud M. A., et al.
Publicado: (2021)

Solid formulation of a supersaturable self-microemulsifying drug delivery system for valsartan with improved dissolution and bioavailability
por: Yeom, Dong Woo, et al.
Publicado: (2017)

Formulation and characterization of Cefuroxime Axetil nanoemulsion for improved bioavailability
por: Patel, Yomesh, et al.
Publicado: (2012)

Formulation and Characterization of Metformin-Loaded Ethosomes for Topical Application to Experimentally Induced Skin Cancer in Mice
por: Mousa, Ibrahim A., et al.
Publicado: (2022)

Tailoring Apixaban in Nanostructured Lipid Carrier Enhancing Its Oral Bioavailability and Anticoagulant Activity
por: Zaky, Mohamed F., et al.
Publicado: (2022)

Improving Anti-Cancer Potentiality and Bioavailability of Gallic Acid by Designing Polymeric Nanocomposite Formulation
por: Ahmed, Hanaa H, et al.
Publicado: (2018)

Novel Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) for Oral Delivery of Olmesartan Medoxomil: Design, Formulation, Pharmacokinetic and Bioavailability Evaluation
por: Nasr, Ali, et al.
Publicado: (2016)

Design of Chronomodulated Drug Delivery System of Valsartan: In Vitro Characterization
por: Sokar, M., et al.
Publicado: (2015)

Formulation and Evaluation of Novel Additive-Free Spray-Dried Triamcinolone Acetonide Microspheres for Pulmonary Delivery: A Pharmacokinetic Study
por: Amran, Mohammed, et al.
Publicado: (2022)

Starch Nanoparticles for Enhancement of Oral Bioavailability of a Newly Synthesized Thienopyrimidine Derivative with Anti-Proliferative Activity Against Pancreatic Cancer
por: Gardouh, Ahmed R, et al.
Publicado: (2021)

Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol
por: Balata, Gehan F, et al.
Publicado: (2016)

Preparation and Evaluation of Valsartan Liquid Filling Formulations for Soft Gels
por: Sanaboina, Jyothi, et al.
Publicado: (2013)

Rosuvastatin calcium nanoparticles: Improving bioavailability by formulation and stabilization codesign
por: Alshora, Doaa H., et al.
Publicado: (2018)

A validated RP-HPLC method for simultaneous determination of propranolol and valsartan in bulk drug and gel formulation
por: Imam, Syed Sarim, et al.
Publicado: (2013)

Nanostructured Valsartan Microparticles with Enhanced Bioavailability Produced by High-Throughput Electrohydrodynamic Room-Temperature Atomization
por: Prieto, Cristina, et al.
Publicado: (2021)

Formulation and Optimization of Nanospanlastics for Improving the Bioavailability of Green Tea Epigallocatechin Gallate
por: Mazyed, Eman A., et al.
Publicado: (2021)

Development of Self-Administered Formulation to Improve the Bioavailability of Leuprorelin Acetate
por: Okada, Akie, et al.
Publicado: (2022)

Formulations with microencapsulated Fe–peptides improve in vitro bioaccessibility and bioavailability
por: Gaigher, Bruna, et al.
Publicado: (2022)

A Liposomal Formulation for Improving Solubility and Oral Bioavailability of Nifedipine
por: Bi, Ye, et al.
Publicado: (2020)

Formulation and Characterization of Eplerenone Nanoemulsion Liquisolids, An Oral Delivery System with Higher Release Rate and Improved Bioavailability
por: Khames, Ahmed
Publicado: (2019)

Sustainable Stabilizer-Free Nanoparticle Formulations of Valsartan Using Eudragit(®) RLPO
por: Hajba-Horváth, Eszter, et al.
Publicado: (2021)

Study of Formulation and Process Variables for Optimization of Piroxicam Nanosuspension Using 3(2) Factorial Design to Improve Solubility and In Vitro Bioavailability
por: Alhamhoom, Yahya, et al.
Publicado: (2023)

Formulation Approaches for Improving the Dissolution Behavior and Bioavailability of Tolvaptan Using SMEDDS
por: Lee, Jong-Hwa, et al.
Publicado: (2022)

Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans
por: Hofmann, Jiří, et al.
Publicado: (2023)

Improved Bioavailability of Ebastine through Development of Transfersomal Oral Films
por: Islam, Nayyer, et al.
Publicado: (2021)

Enhancing the Low Oral Bioavailability of Sulpiride via Fast Orally Disintegrating Tablets: Formulation, Optimization and In Vivo Characterization
por: M. Tawfeek, Hesham, et al.
Publicado: (2020)

Quality by Design for the Development and Analysis of Enhanced In-Situ Forming Vesicles for the Improvement of the Bioavailability of Fexofenadine HCl In Vitro and In Vivo
por: Nasr, Ali M., et al.
Publicado: (2020)

Engineering of solidified glyburide nanocrystals for tablet formulation via loading of carriers: downstream processing, characterization, and bioavailability
por: Ali, Hany S M, et al.
Publicado: (2019)

Formulation and Bioequivalence of Two Valsartan Tablets After a Single Oral Administration
por: Zaid, Abdel Naser, et al.
Publicado: (2011)

Boosting the anti MERS-CoV activity and oral bioavailability of resveratrol via PEG-stabilized emulsomal nano-carrier: Factorial design, in-vitro and in-vivo assessments
por: Zakaria, Mohamed Y., et al.
Publicado: (2022)

Design of novel proliposome formulation for antioxidant peptide, glutathione with enhanced oral bioavailability and stability
por: Byeon, Jong Chan, et al.
Publicado: (2019)

Comprehensive Study of Atorvastatin Nanostructured Lipid Carriers through Multivariate Conceptualization and Optimization
por: Ghanem, Heba A., et al.
Publicado: (2021)

Lipid/Clay-Based Solid Dispersion Formulation for Improving the Oral Bioavailability of Curcumin
por: Song, Jae Geun, et al.
Publicado: (2022)

Nanotechnology-based formulations to amplify intraocular bioavailability
por: Kagkelaris, Konstantinos, et al.
Publicado: (2022)

Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate
por: Watkins, Melynda E., et al.
Publicado: (2017)

Bioavailability Study of an Innovative Orobuccal Formulation of Glutathione
por: Buonocore, Daniela, et al.
Publicado: (2016)

Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update
por: Lin, Yiping, et al.
Publicado: (2021)

Improved Dissolution and Oral Bioavailability of Valsartan Using a Solidified Supersaturable Self-Microemulsifying Drug Delivery System Containing Gelucire(®) 44/14
por: Shin, Dong Jun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nk785hb481i410agk82i8bfji4